Pharmacotherapy for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacotherapy for chronic obstructive pulmonary disease

Published:2019 Issue:5 Volume:62 Page:277
ISSN:1975-8456
Container-title:Journal of the Korean Medical Association
language:ko
Short-container-title:J Korean Med Assoc

Author:

Jo Yong Suk¹^ORCID,Park Yong Bum¹²^ORCID

Affiliation:

1. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

2. Lung Research Institute, Hallym University College of Medicine, Chuncheon, Korea.

Publisher

Korean Medical Association (KAMJE)

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.5124/jkma.2019.62.5.277

Reference26 articles.

1. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

2. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

3. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

4. Comparison of Domiciliary Nebulized Salbutamol and Salbutamol From a Metered-dose Inhaler in Stable Chronic Airflow Limitation

5. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP